Lianovation(SH:600363) Zheng Quan Shi Bao Wang·2025-12-31 14:10Group 1: AI Medical Industry Outlook - The AI medical industry is expected to maintain high prosperity due to continuous breakthroughs in AI technology and increasing healthcare demands [1] - The integration of AI in the medical field is becoming a core driver for industry development, with significant policy support from the government [5][4] - The global AI medical market is projected to grow at a compound annual growth rate (CAGR) of 43% from 2024 to 2032, potentially exceeding $491 billion [5] Group 2: Beijing's Support for AI in Healthcare - Beijing's health commission has introduced the "Action Plan" and "Several Measures" to support the development of AI in healthcare, focusing on core application scenarios and expanding application areas [3][4] - The "Action Plan" outlines 16 key tasks aimed at promoting collaboration between medical institutions and AI companies, with a goal to establish a robust AI industry support system by 2027 [3] Group 3: Market Performance of AI Medical Stocks - AI medical concept stocks have seen an average increase of 18.75% this year, with five stocks rising over 50% [6] - Haoyuan Pharmaceutical has the highest cumulative increase of 102.86% this year, reflecting strong market interest and institutional attention [8][6] - Yunnan Baiyao has been the most frequently researched stock, with 41 institutional surveys conducted this year, indicating significant investor interest [8]